Ovarian Cancer Trial, Not Yet Recruiting NCT07057167 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT07057167
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 years or older.
  • People diagnosed with advanced ovarian cancer at a specific stage (FIGO stage IIIB to IVB, which refers to cancer that has spread to the lining of the abdomen or beyond).
  • People who are well enough to undergo upfront surgery to remove as much of the cancer as possible (called cytoreductive surgery).
  • People who are having a keyhole diagnostic procedure (laparoscopy) as part of the initial planning for their treatment.
  • People treated at the Fondazione Policlinico Universitario A. Gemelli IRCCS who have signed the required consent forms for participation and use of personal data in research (or where a substitute declaration has been completed for deceased patients).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose records do not include sufficient information about their surgical results or medical and pathological details.
  • People with ovarian cancer where there is no visible spread to the lining of the abdomen (corresponding to earlier stages, FIGO stage I to IIIA).
  • People who are having a second round of surgery to remove cancer that has come back (secondary cytoreductive surgery), rather than surgery at the time of first diagnosis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna Fagotti, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630157004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 November 2025
Est. completion
10 October 2026

Primary endpoints

Accuracy of Computer Vision Algorithm in Predicting Ovarian Cancer Histotype

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov